Immuno-effect of Tα1 for Stage I NSCLC

Clinical trial NCT06598839 · RECRUITING

Trial details

NCT number: NCT06598839
Sponsor: Yousheng Mao
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2024-06-30
Primary completion: 2025-09-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.